The move by Chinese scientists could spark a biomedical duel between China and the United States.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
CRISPR/Cas9: a powerful tool in colorectal cancer research
Journal of Experimental & Clinical Cancer Research Open Access 22 November 2023
-
Innovations in Skin and Soft Tissue Aging—A Systematic Literature Review and Market Analysis of Therapeutics and Associated Outcomes
Aesthetic Plastic Surgery Open Access 08 May 2023
-
Chronic myeloid leukemia stem cells: targeting therapeutic implications
Stem Cell Research & Therapy Open Access 18 December 2021
Access options
Subscribe to this journal
Receive 51 print issues and online access
202,72 € per year
only 3,97 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Related links
Related links
Related links in Nature Research
Chinese scientists to pioneer first human CRISPR trial 2016-Jul-21
First CRISPR clinical trial gets green light from US panel 2016-Jun-22
Leukaemia success heralds wave of gene-editing therapies 2015-Nov-05
Where in the world could the first CRISPR baby be born? 2015-Oct-13
CRISPR, the disruptor 2015-Jun-03
CRISPR: The good, the bad and the unknown
Related external links
Rights and permissions
About this article
Cite this article
Cyranoski, D. CRISPR gene-editing tested in a person for the first time. Nature 539, 479 (2016). https://doi.org/10.1038/nature.2016.20988
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature.2016.20988
This article is cited by
-
An Update on the Application of CRISPR Technology in Clinical Practice
Molecular Biotechnology (2024)
-
Tumor Microenvironment Regulates Immune Checkpoints: Emerging Need of Combinatorial Therapies
Current Tissue Microenvironment Reports (2024)
-
CRISPR/Cas9: a powerful tool in colorectal cancer research
Journal of Experimental & Clinical Cancer Research (2023)
-
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy
Cancer Gene Therapy (2023)
-
Novel biomolecules in targeted cancer therapy: a new approach towards precision medicine
Medical Oncology (2023)